Completed Research
Applying Behavioral Economic Incentives to Support Implementation of PrEP in a Trans Community Center
This project plans to leverage our ongoing community-academic collaboration to conduct a sequential cohort design where three cohorts of transgender/non-binary participants will be recruited from a transgender-based community center currently implementing a community-led PrEP program to collect preliminary data on the acceptability, feasibility, and preliminary effects of three discrete behavioral economic approaches for encouraging engagement in the PrEP program currently being implemented at the Los Angeles Trans Wellness Center.
(NIMH P30 MH058107-26S5)
Examining the Associations of Structural Factors, Substance Use, Mental Health, and Resilience with HIV Care Engagement and Viral Suppression among Young Black Sexual Minority Men
Risk and Protective Factors for Adherence to Pre-Exposure Prophylaxis (PrEP) in Transgender Women of Color
This study leveraged an ongoing study of racially and ethnically diverse trans women enrolled in the Southern California based PrEP demonstration project, in order to conduct mixed-methods research to assess the risk and resiliency factors most associated with PrEP adherence among trans women of color.
(NIDA R21 DA044073)
Developing a PrEP Screening Instrument for Identification/Referral of High-Risk MSM in Primary Care
This mixed methods study developed and pilot-tested a PrEP screening instrument for the facilitation of PrEP uptake among MSM that was integrated into primary care clinic workflow based on provider-identified barriers and facilitators to sexual- health screening.
(NIDA R03 DA043402)
Investigating Resiliency in Preventing Binge Drinking and Stimulant Use among Black Men at High-risk for HIV
This project supported secondary analyses to determine the extent to which resiliency, gay pride/self-esteem, and social support moderated the relationship between stressful experiences of racism, homophobia, and internalized homophobia and the use of alcohol and other drugs among Black men at high-risk for HIV.
(NIDA R03 DA042660)